**Summary Report**: 
- Second quarter 2017 GAAP earnings per share of $3.16 and adjusted earnings per share of $3.37
- Membership and revenue tracking well
- Membership growth in commercial insured business
- Ended the quarter with nearly 40.4 million members
- Operating revenues of $22.2 billion, an increase of $924 million or 4.3% versus the second quarter of 2016
- Commercial business and Government segments contributing to strong financial performance
- Commercial operating margin for the second quarter of 2017 declined by 150 basis points from the second quarter of 2016
- Individual ACA-compliant business operating at a slight loss for the year
- Medicaid business performance largely in line with expectations
- Medicare business core gross margin performance in line with expectations
- Adjusted earnings per share of greater than $11.70 for the full year 2017
- Analyzing options for a long-term pharmacy solution with the goal to lower pharmacy costs by more than $3 billion annually
- Always been committed to addressing the evolving policy landscape and contributing to ongoing discussions in Washington and states on behalf of members and all Americans
- Continuously monitoring state and federal legislative and regulatory developments in healthcare
- Engaged in a very analytical process for the pharmacy benefit manager (PBM) strategy and remains committed to informing the market of the long-term pharmacy strategy by the end of 2017
- Continually assessing legislative and market conditions for the Individual ACA-compliant marketplace in order to make rate adjustments and determine the level of market participation
- Focused on expanding access to high-quality affordable healthcare and committed to confronting tough questions and challenges in the healthcare delivery system